Adipose-Derived Mesenchymal Stem Cells and Conditioned Medium Attenuate the Memory Retrieval Impairment During Sepsis

Fariba Akhondzadeh1, Mehri Kadkhodaee1, Behjat Seifi1

  • 1Department of Physiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran.

Insights

Sepsis impairs memory retrieval, but mesenchymal stem cells (MSCs) and MSC-conditioned medium (MSC-CM) treatments improve memory and reduce sepsis severity in rats. MSC-CM shows greater therapeutic potential.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Sepsis is a life-threatening condition associated with cognitive dysfunction, including memory impairment.
  • Mesenchymal stem cells (MSCs) and their conditioned medium (MSC-CM) are being investigated for their therapeutic potential in inflammatory diseases.

Purpose of the Study:

  • To investigate the effects of sepsis on memory retrieval in rats.
  • To evaluate the therapeutic efficacy of transplanted MSCs and MSC-CM in mitigating sepsis-induced memory deficits and other complications.

Main Methods:

  • Sepsis was induced using the cecal ligation and puncture (CLP) model in rats.
  • Experimental groups included sham, CLP, MSC treatment, and MSC-CM treatment.
  • Memory retrieval was assessed using the novel object recognition test, alongside sepsis scoring, blood pressure measurement, and hippocampal protein analysis (Western blot).

Main Results:

  • CLP rats exhibited increased sepsis scores, elevated blood pressure, and hippocampal alterations (increased p-CAMKII-α, cleaved caspase 3, Bax/Bcl2 ratio; decreased c-fos).
  • Both MSC and MSC-CM treatments significantly reduced sepsis severity, stabilized blood pressure, and improved memory retrieval compared to CLP rats.
  • MSC-CM demonstrated a more advantageous therapeutic effect compared to MSC transplantation.

Conclusions:

  • Sepsis induction impairs memory retrieval in rats, partly mediated by hippocampal CAMKII and c-fos pathways.
  • MSC transplantation and MSC-CM administration effectively attenuate sepsis-induced memory deficits and systemic complications.
  • MSC-CM presents a promising cell-free therapeutic strategy for managing severe sepsis and its neurological sequelae.